Evidence map›Paper›PMID 42825346›Full record

ArticleJournal of global health2026

Prevalence of abnormal spirometry and correlates of lung function decline among a population in rural Uganda.

Marvah Hill Pierre-Louis, Yiqi Qian, Emily N Satinsky, Edwin Nuwagira, Charles Baguma, Patience Ayebare, Patrick Gumisiriza, Megan Lam, Mi-Sun Lee, David C Christiani and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marvah Hill Pierre-LouisPulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Yiqi QianMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Emily N SatinskyCenter for Global Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
Edwin NuwagiraMbarara University of Science and Technology, Mbarara, Uganda.
Charles BagumaMbarara University of Science and Technology, Mbarara, Uganda.
Patience AyebareMbarara University of Science and Technology, Mbarara, Uganda.
Patrick GumisirizaMbarara University of Science and Technology, Mbarara, Uganda.
Megan LamMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Mi-Sun LeeHarvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
David C ChristianiPulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Stephen AsiimweCenter for Global Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
Bernard KakuhikireMbarara University of Science and Technology, Mbarara, Uganda.
Alexander C TsaiCenter for Global Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
Mark J SiednerMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Crystal M NorthPulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic lung disease, which is the third leading cause of death globally, places a disproportionate burden of morbidity and mortality on sub-Saharan Africa, where limited infrastructure results in a lack of understanding of how lung function changes over time, whether it varies among susceptible populations, or whether at-risk individuals could be identified before abnormal lung function develops. To address this gap, we aimed to characterise lung function patterns and identify correlates of lung function decline in rural Uganda. Methods: Adults completed health questionnaires and American Thoracic Society/European Respiratory Society-acceptable spirometry up to three times over four years (2015-2019). Our primary outcome was lung function (forced expiratory volume in 1 second (EV Results: A total of 902 participants completed 1,471 ATS/ERS-acceptable spirometry tests. Their median age was 35 years, 56% were women, 75% were never-smokers, and 31% experienced chronic respiratory symptoms. Abnormal lung function affected 14% of the cohort, more commonly women and those with respiratory symptoms. FEV Conclusions: Lung function decline may be more rapid in this young, mostly non-smoking population. Our findings extend the understanding of non-obstructive lung disease in sub-Saharan Africa and emphasise that risk persists despite normal spirometry. These data can inform regional public health strategies for risk mitigation, early disease detection, and building healthcare infrastructure for the growing population at risk for or living with chronic lung disease.

Indexed as

LungLung DiseasesRural PopulationSpirometryAdultFemaleForced Expiratory VolumeHumansMaleMiddle AgedPrevalenceRespiratory Function TestsUgandaVital CapacityYoung Adultasthmachronic lung diseaseCOPDpulmonary function testingresource-limited setting(s)

Identifiers

PMID42825346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.